VitaSpring Biomedical Co. Ltd. VSBC
OTC PK
| 07/31/2026 | 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 449.20K | 386.50K | 379.80K | 425.40K | 407.60K |
| Depreciation & Amortization | 5.00K | 5.00K | 5.00K | 5.00K | 5.00K |
| Other Operating Expenses | -- | -- | -- | 0.00 | 0.00 |
| Total Operating Expenses | 454.20K | 391.50K | 384.80K | 430.40K | 412.60K |
| Operating Income | -454.20K | -391.50K | -384.80K | -430.40K | -412.60K |
| Income Before Tax | -448.80K | -392.10K | -385.40K | -430.40K | -412.60K |
| Income Tax Expenses | 6.80K | 18.60K | 30.00K | 46.60K | 118.20K |
| Earnings from Continuing Operations | -0.46 | -0.41 | -0.42 | -0.48 | -0.53 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -455.60K | -410.60K | -415.30K | -476.90K | -530.70K |
| EBIT | -454.20K | -391.50K | -384.80K | -430.40K | -412.60K |
| EBITDA | -445.20K | -381.60K | -374.90K | -420.50K | -402.70K |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 828.12M | 828.12M | 828.12M | 828.12M | 828.12M |
| Average Diluted Shares Outstanding | 828.12M | 828.12M | 828.12M | 828.12M | 828.12M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |